Understanding Unapproved Use of Approved Drugs “Off Label” (2018)

Government Record · U.S. Food and Drug Administration · February 5, 2018

U.S. Food, 2018-02-05: FDA's own patient-facing explainer stating that, once a drug is approved, prescribers generally may prescribe it off-label when they judge it medically appropriate.

once the FDA approves a drug, healthcare providers generally may prescribe the drug for an unapproved use when they judge that it is medically appropriate for their patient

U.S. Food, 2018-02-05: FDA's own patient-facing explainer stating that, once a drug is approved, prescribers generally may prescribe it off-label when they judge it medically appropriate. C11 and F4. Access date 2026-11-19, page undated (no publication or revision date is printed on it). This is the agency's general off-label policy statement, and it directly contradicts the book's claim that oncologists are 'forbidden' to prescribe off-label. Note the limits the same page states: off-label use is not itself an approval, and the evidentiary support differs from an approved indication. Also filed as IVA-67 (claims C11, F4). Study type: regulatory record.